GF Fund Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.44K Hold
958
﹤0.01% 611
2025
Q1
$8.66K Buy
958
+173
+22% +$1.56K ﹤0.01% 582
2024
Q4
$13.6K Buy
+785
New +$13.6K ﹤0.01% 508